Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies.

RubrYc has developed a unique molecular engineering approach to the discovery of epitope-selective antibodies. By combining greatly parallel in silico simulations, proprietary machine learning ...